Overview
Tina Dasgupta is a Radiation Oncologist in Atlanta, Georgia. Dr. Dasgupta has been practicing medicine for over 18 years. Her top areas of expertise are Glioma, Gliomatosis Cerebri, and Astrocytoma. Dr. Dasgupta is currently accepting new patients.
Her clinical research consists of co-authoring 5 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Graduate Year
Specialties
Licenses
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
Locations
5665 Peachtree Dunwoody Road, Atlanta, GA 30342
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Emory Winship Cancer Institute
Hui-kuo Shu is a Radiation Oncologist in Atlanta, Georgia. Dr. Shu has been practicing medicine for over 33 years is highly rated in 30 conditions, according to our data. His top areas of expertise are Glioblastoma, Astrocytoma, Brain Tumor, and Glioma.
Emory Winship Cancer Institute
Ashesh Jani is a Radiation Oncologist in Atlanta, Georgia. Dr. Jani has been practicing medicine for over 31 years is highly rated in 6 conditions, according to our data. His top areas of expertise are Prostate Cancer, Muscle Invasive Bladder Cancer, Familial Prostate Cancer, Upper Tract Urothelial Carcinoma (UTUC), and Prostatectomy.
Emory Winship Cancer Institute
Jim Zhong is a Radiation Oncologist in Atlanta, Georgia. Dr. Zhong is highly rated in 20 conditions, according to our data. His top areas of expertise are Astrocytoma, Meningioma, Glioblastoma, Splenectomy, and Pancreaticoduodenectomy.
Frequently Asked Questions about Dr. Tina Dasgupta
How do I make an appointment with Dr. Tina Dasgupta?
You can book an appointment with Dr. Tina Dasgupta by calling their office at 404-365-0966. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Tina Dasgupta a top-rated expert for Glioma?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Tina Dasgupta is classified as an Experienced expert for Glioma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Tina Dasgupta specialize in?
While Dr. Tina Dasgupta is a Radiation Oncology, they have specific expertise in Glioma, Gliomatosis Cerebri, and Astrocytoma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Radiation Oncology.
Does Dr. Tina Dasgupta participate in research or clinical trials?
Yes. Dr. Tina Dasgupta has published 5 articles and abstracts on conditions like Glioma. You can view a list of Dr. Tina Dasgupta's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Tina Dasgupta accept my insurance?
Dr. Tina Dasgupta accepts most major insurance plans, including Kaiser. We recommend calling the office directly at 404-365-0966 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- AstrocytomaDr. Dasgupta isExperienced. Learn about Astrocytoma.
- GliomaDr. Dasgupta isExperienced. Learn about Glioma.
- Gliomatosis CerebriDr. Dasgupta isExperienced. Learn about Gliomatosis Cerebri.


